CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-17 | MARCUS JOEL S Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-08-17 | MARCUS JOEL S Director | Returned to the company · Stock Option | −14,846 | 0 | ||
| 2022-08-17 | LANGER ROBERT Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-08-17 | LANGER ROBERT Director | Returned to the company · Stock Option | −14,846 | 0 | ||
| 2022-08-17 | LANGER ROBERT Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-08-17 | LANGER ROBERT Director | Returned to the company · Stock Option | −14,846 | 0 | ||
| 2022-08-17 | Huang Michael Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-08-17 | Huang Michael Director | Returned to the company · Stock Option | −14,846 | 0 | ||
| 2022-08-17 | Huang Michael Director | Grant or award · Stock Option | +14,846 | 14,846 | ||
| 2022-08-17 | Huang Michael Director | Returned to the company · Stock Option | −14,846 | 0 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Grant or award · Stock Option | +714,413 | 714,413 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Returned to the company · Stock Option | −714,413 | 0 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Grant or award · Stock Option | +242,500 | 242,500 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Returned to the company · Stock Option | −242,500 | 0 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2022-08-17 | Lucchino David L. President and CEO | Returned to the company · Stock Option | −200,000 | 0 | ||
| 2022-08-17 | LeBel Carl Chief Development Officer | Grant or award · Stock Option | +178,937 | 178,937 | ||
| 2022-08-17 | LeBel Carl Chief Development Officer | Returned to the company · Stock Option | −178,937 | 0 | ||
| 2022-08-17 | LeBel Carl Chief Development Officer | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2022-08-17 | LeBel Carl Chief Development Officer | Returned to the company · Stock Option | −75,000 | 0 |
Page 17 of 23 · 441 trades